Related references
Note: Only part of the references are listed.Dasatinib - In chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Susan J. Keam
BIODRUGS (2008)
Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate
Michael Brave et al.
CLINICAL CANCER RESEARCH (2008)
Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma
Junji Komori et al.
HEPATOLOGY (2008)
Efficient retroviral transduction of human B-lymphoid and myeloid progenitors:: marked inhibition of their growth by the Pax5 transgene
Rieko Sekine et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Inactivation of NF-κB components by covalent binding of (-)-dehydroxymethylepoxyquinomicin to specific cysteine residues
Mizuki Yamamoto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells
Niklas Feldhahn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Resistance to imatinib of Bcr/Abl p190 lymphoblastic leukemia cells
Suparna Mishra et al.
CANCER RESEARCH (2006)
Targeting NF-κB in hematologic malignancies
T Braun et al.
CELL DEATH AND DIFFERENTIATION (2006)
In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals
Y Inoue et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer
M Karin et al.
CELL (2006)
Acute myelogenous leukemia - microenvironment interactions: Role of endothelial cells and proteasome inhibition
JL Liesveld et al.
HEMATOLOGY (2005)
The kinase inhibitor imatinib mesylate inhibits TNF-α production in vitro and prevents TNF-dependent acute hepatic inflammation
AM Wolf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells
S Cuní et al.
LEUKEMIA (2004)
Constitutive NF-κB/Rel activation in Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL)
G Munzert et al.
LEUKEMIA & LYMPHOMA (2004)
Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector
Y Bai et al.
GENE THERAPY (2003)
Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL)
B Wassmann et al.
LEUKEMIA (2002)
BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571:: a prospective study
N von Bubnoff et al.
LANCET (2002)
Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis
B Gleissner et al.
BLOOD (2002)
Ph+ acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation
WK Hofmann et al.
BLOOD (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)
SM Garrido et al.
EXPERIMENTAL HEMATOLOGY (2001)
Transcription factor NF-kappa B is constitutively activated in acute lymphoblastic leukemia cells
U Kordes et al.
LEUKEMIA (2000)